Valion Bio, Inc. (VBIO) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2021: $1.29M2022: $1.54M2023: $889.0K2024: $778.0K$778.0K
2021Cost of Revenue (USD)2024
Fiscal YearCost of RevenueChange YoY
2024$778.0K-12.5%
2023$889.0K-42.3%
2022$1.54M+19.0%
2021$1.29M